Chih-Hung Chiang
Overview
Explore the profile of Chih-Hung Chiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer
Yang C, Tan Z, Yang J, Hsu F, Chiang C
Biomed Pharmacother
. 2023 Jun;
164:114962.
PMID: 37276643
Bladder cancer is known as one of the top ten most common cancer types worldwide and can be majorly divided into muscles invasive bladder cancer (MIBC) and non-muscles invasive type...
12.
Chiu P, Leow J, Chiang C, Mok A, Zhang K, Hsieh P, et al.
J Urol
. 2023 May;
210(1):98.
PMID: 37139611
No abstract available.
13.
Chiu P, Leow J, Chiang C, Mok A, Zhang K, Hsieh P, et al.
J Urol
. 2023 Apr;
210(1):88-98.
PMID: 37036248
Purpose: We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy. Materials And Methods: This is a multicenter...
14.
Chiang C, Chang C, Huang H, Chen Y, Tsai P, Jeng S, et al.
Biomed Res Int
. 2022 Dec;
2022:9794832.
PMID: 36471685
[This corrects the article DOI: 10.1155/2011/219060.].
15.
Chang T, Chiang C, Chen C, Lin S, Lee H, Chen J
Biomed Pharmacother
. 2022 May;
151:113139.
PMID: 35623171
Reactive oxygen species (ROS) and oxidative stress are associated with the progression of diabetic nephropathy (DN). Hydralazine is an antihypertensive agent and may act as a xanthine oxidase (XO) inhibitor...
16.
Hong J, Tong Z, Wei T, Lu Y, Huang C, Huang C, et al.
Mol Cancer Ther
. 2022 Mar;
21(6):1010-1019.
PMID: 35312783
Cisplatin-based chemotherapy is the first-line therapy for bladder cancer. However, cisplatin resistance has been associated with the recurrence of bladder cancer. Previous studies have shown that activation of FGFR and...
17.
Chiu S, Cheng Y, Pu Y, Lu Y, Hong J, Chung S, et al.
Front Oncol
. 2021 Dec;
11:772182.
PMID: 34869007
Background: Prostate-specific antigen (PSA) is considered neither sensitive nor specific for prostate cancer (PCa). We aimed to compare total PSA (tPSA), percentage of free PSA (%fPSA), the PSA density (PSAD),...
18.
Liu Y, Chiang I, Chung J, Hsieh J, Chiang C, Weng M, et al.
In Vivo
. 2020 Nov;
34(6):3217-3224.
PMID: 33144426
Background: Although both chemotherapy and radiotherapy (RT) can sufficiently maintain tumor suppression of colorectal cancer (CRC), these treatments may trigger the expression of nuclear factor kappa B (NF-κB) and compromise...
19.
Hong J, Lee P, Lu Y, Huang C, Chen C, Chiang C, et al.
Urol Oncol
. 2020 Mar;
38(5):465-475.
PMID: 32199754
Background: Urothelial carcinomas (UCs) are highly prevalent in patients with end-stage renal disease. Chronic kidney disease (CKD) is the predecessor of end-stage renal disease, and it is also associated with...
20.
Cheng Y, Huang C, Chen C, Chiu S, Hong J, Pu Y, et al.
Sci Rep
. 2020 Jan;
10(1):776.
PMID: 31964956
To evaluate the predictive accuracy of the %p2PSA and prostate health index (PHI) in predicting aggressive pathological outcomes in patients with prostate cancer (PCa) undergoing radical prostatectomy (RP), we enrolled...